RxDoctor Payments Data

Christopher Abercrombie, DO

Family Medicine · Arnold, MONPI 1093787558

Payments from drug & device makers

$16,234in general payments, 2019–2025

Across 962 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • AstraZeneca$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • GSK$874
  • Pfizer$705
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$16,234100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)280$5,116
AstraZeneca73$1,375
Novo Nordisk75$1,162
Lilly USA, LLC64$1,132
GSK75$874
Pfizer52$705
Amgen31$494
Amarin Pharma, Inc.26$398
Abbott15$332
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$314
Otsuka America Pharmaceutical, Inc.16$309
Axsome Therapeutics, Inc.13$308
Boehringer Ingelheim19$286
Exact Sciences13$251
Bayer15$247
Sanofi-aventis U.S. LLC13$226
Takeda Pharmaceuticals U.S.A., Inc.13$222
Tris Pharma Inc10$168
Biohaven Pharmaceuticals, Inc.9$144
Ironwood Pharmaceuticals, Inc8$135
Merck9$133
Johnson & Johnson7$119
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$118
Novartis8$113
Eisai Inc.6$104
Esperion Therapeutics, Inc.6$98
Biohaven Pharmaceutical Holding Company Ltd.6$94
Antares Pharma, Inc.6$93
Kowa Pharmaceuticals America, Inc.6$88
Astellas Pharma US Inc6$85
Azurity Pharmaceuticals, Inc.5$79
Lundbeck LLC3$68
Supernus Pharmaceuticals, Inc.3$57
Aytu Biopharma, Inc.1$56
Teva Pharmaceuticals USA, Inc.4$55
Insulet Corporation2$53
Phathom Pharmaceuticals, Inc.3$52
Corium, LLC2$48
Corcept Therapeutics3$46
Almatica Pharma LLC2$44
Adlon Therapeutics L.p.3$42
Jazz Pharmaceuticals Inc.2$41
Arbor Pharmaceuticals, Inc.3$40
Dexcom, Inc.2$29
Sumitomo Pharma America, Inc.1$26
Redhill Biopharma Inc.1$22
Tempus AI, Inc1$22
Optinose US, Inc.1$21
Ironshore Pharmaceuticals Inc.1$20
Ultragenyx Pharmaceutical Inc.1$19
Neos Therapeutics, LP1$18
Acerus Pharmaceuticals Corporation1$18
Ardelyx, Inc.1$17
E.r. Squibb & Sons, L.L.C.1$16
Sanofi Pasteur Inc.1$15
Circassia Inc.1$15
Alfasigma USA, Inc.1$15
Scilex Pharmaceuticals Inc.1$13
Idorsia Pharmaceuticals US Inc1$13
Avion Pharmaceuticals1$12

How this compares

$16,234 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$35,182
Medicare patients
124
Services billed
575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol115$130,250
EliquisApixaban94$120,295
OzempicSemaglutide48$79,845
JardianceEmpagliflozin63$78,995
Trelegy ElliptaFluticasone/Umeclidin/Vilanter63$68,153
MounjaroTirzepatide61$65,810
XareltoRivaroxaban32$30,527
RybelsusSemaglutide16$19,549
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$19,353
VascepaIcosapent Ethyl17$18,106
TradjentaLinagliptin25$16,922
SymbicortBudesonide/Formoterol Fumarate34$14,162
LinzessLinaclotide15$10,893
KerendiaFinerenone12$9,054
Breo ElliptaFluticasone/Vilanterol11$7,939

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,375$163,766166 claims
PfizerEliquis, Abrysvo$705$123,908109 claims
Novo NordiskOzempic, Rybelsus$1,162$99,39464 claims
Boehringer IngelheimJardiance, Tradjenta$286$95,91788 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy$874$80,33090 claims
Lilly USA, LLCMounjaro$1,132$65,81061 claims
Johnson & JohnsonXarelto$119$30,52732 claims
AbbVieLinzess$5,116$10,89315 claims
BayerKerendia$247$9,05412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Arnold

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →